Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of reproductive age who want to have children in the future
- People who are willing to be managed without immediate surgical treatment (conservative approach)
- People who are committed to attending all scheduled follow-up appointments
- People whose colposcopy (a close-up examination of the cervix) shows a fully visible area where certain cell types meet, with significant abnormal changes that can be seen in their entirety, and no involvement of the inner cervical canal
- People whose colposcopy shows significant abnormal changes that cover less than half of the cervical surface
Who may not be able to join:
- People who are pregnant at their first visit or who become pregnant during the follow-up period
- People whose immune system is weakened, whether due to medication or due to HIV infection
- People who have suspected or confirmed abnormal glandular cells, a type of pre-cancer called adenocarcinoma in situ, or cervical cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cristina Vanrell Barbat, MD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phone: +34604311873
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
HSIL regression; Cytology; Biopsy; VPH
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.